Association between lung function and future risks of diabetes, asthma, myocardial infarction, hypertension and all-cause mortality
JournalERJ Open Research
PublisherEuropean Respiratory Society
MetadataShow full item record
AbstractBACKGROUND: While forced expiratory volume in 1 s (FEV1) is a hallmark of disease progression in chronic obstructive lung diseases, little is known about the relationship between baseline FEV1 and future risks of other medical conditions. OBJECTIVE: The aim of this study was to investigate the association between baseline FEV1 and future risks of diabetes, asthma, myocardial infarction, hypertension and all-cause mortality. METHODS: We used data from the National Health and Nutrition Examination Survey and its Epidemiological Follow-Up Study. Our data provided longitudinal follow-up of the original cohort for up to 12 years. We used two competing risks approaches, the cause-specific hazard model and the Fine-Gray sub-distribution hazard model, to measure the associations between baseline FEV1 and future risks of the outcomes of interest. All models were adjusted for major confounding factors. RESULTS: The final sample included 3020 participants (mean±sd baseline age 44.64±13.44 years). In the cause-specific hazard model, for every per cent increase in the baseline per cent predicted FEV1, the hazard of the event reduced by 2.5% (HR 0.975; 95% CI 0.958-0.994) for diabetes, 4.3% (HR 0.957; 95% CI 0.932-0.983) for asthma and 1.8% (HR 0.982; 95% CI 0.971-0.992) for all-cause mortality. There was no statistically significant association between baseline per cent predicted FEV1 and future risks of myocardial infarction (HR 0.987; 95% CI 0.970-1.004) and hypertension (HR 0.998; 95% CI 0.992-1.005). Consistent results were observed for the Fine-Gray sub-distribution hazard model. CONCLUSION: Our data suggest that lower per cent predicted FEV1 values at baseline were significantly associated with higher future risks of diabetes, asthma and all-cause mortality.
Rights/TermsCopyright ©The authors 2021.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/16707
- Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV<sub>1</sub> (PURE): an international, community-based cohort study.
- Authors: Duong M, Islam S, Rangarajan S, Leong D, Kurmi O, Teo K, Killian K, Dagenais G, Lear S, Wielgosz A, Nair S, Mohan V, Mony P, Gupta R, Kumar R, Rahman O, Yusoff K, du Plessis JL, Igumbor EU, Chifamba J, Li W, Lu Y, Zhi F, Yan R, Iqbal R, Ismail N, Zatonska K, Karsidag K, Rosengren A, Bahonar A, Yusufali A, Lamelas PM, Avezum A, Lopez-Jaramillo P, Lanas F, O'Byrne PM, Yusuf S, PURE investigators.
- Issue date: 2019 May
- Accelerated FEV<sub>1</sub> decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients.
- Authors: Whittaker HR, Bloom C, Morgan A, Jarvis D, Kiddle SJ, Quint JK
- Issue date: 2021 Mar
- Association of Nonobstructive Chronic Bronchitis With Respiratory Health Outcomes in Adults.
- Authors: Balte PP, Chaves PHM, Couper DJ, Enright P, Jacobs DR Jr, Kalhan R, Kronmal RA, Loehr LR, London SJ, Newman AB, O'Connor GT, Schwartz JE, Smith BM, Smith LJ, White WB, Yende S, Oelsner EC
- Issue date: 2020 May 1
- Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
- Authors: Sumida K, Kwak L, Grams ME, Yamagata K, Punjabi NM, Kovesdy CP, Coresh J, Matsushita K
- Issue date: 2017 Nov
- Short-term prognostic value of forced expiratory volume in 1 second divided by height cubed in a prospective cohort of people 80 years and older.
- Authors: Turkeshi E, Vaes B, Andreeva E, Matheï C, Adriaensen W, Van Pottelbergh G, Degryse JM
- Issue date: 2015 Feb 25